Leaflet BERODUAL N 0.020mg / 0.050mg inhalation aerosol, solution
Indicated for: nasal congestion; rhinitis
Route of administration: inhalation
Substance: phenoterol + ipratropium (beta-2 adrenergic agonist + antimuscarinic bronchodilator)
ATC: R03AL01 (Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids)
Use caution if you have glaucoma or increased eye pressure.
May cause dry mouth, constipation, urinary retention, or blurred vision.
This medicine may increase blood sugar.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Older people may have an increased risk of side effects.
This medicine may increase the risk of heart rhythm disturbances.
The combination of fenoterol and ipratropium is used to treat obstructive lung diseases such as bronchial asthma and chronic obstructive pulmonary disease (COPD). This combination works synergistically: fenoterol relaxes the airway muscles, while ipratropium reduces secretions and prevents bronchial constriction, making breathing easier.
The medication is usually administered as an inhaler or nebulizer, according to the doctor's instructions. The dose and frequency are determined based on the severity of the disease and the patient's response to treatment. It is important for the patient to carefully follow the instructions regarding the correct use of the inhalation device.
Side effects may include dry mouth, throat irritation, tremors, palpitations, or headaches. In rare cases, severe allergic reactions, difficulty breathing, or heart rhythm disturbances may occur. If such symptoms appear, urgent medical intervention is required.
The combination of fenoterol and ipratropium is effective in rapidly relieving respiratory symptoms, but requires careful monitoring, especially in patients with heart conditions or other health problems. Following medical recommendations and being informed about possible side effects are essential for safe and effective treatment.
General data about BERODUAL N 0.020mg / 0.050mg
- Substance: phenoterol + ipratropium
- Date of last drug list: 01-05-2018
- Commercial code: W13044001
- Concentration: 0.020mg / 0.050mg
- Pharmaceutical form: inhalation aerosol, solution
- Quantity: 1
- Product type: original
- Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.